Egalet to Present at the 13th Annual Needham Healthcare Conference on April 9

Egalet to Present at the 13th Annual Needham Healthcare Conference on April 9

WAYNE, Pa., April 2, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT)
("Egalet") today announced that Bob Radie, president and chief executive
officer, is scheduled to present next week at the 13^th Annual Needham
Healthcare Conference on Wednesday, April 9, 2014, at 2:20 p.m. EDT. The
conference will be held at the Westin NY Grand Central Hotel.

The presentation will be audio webcast live and available for replay at
Egalet's website at http://egalet.investorroom.com/eventsandwebcasts.

About Egalet

Egalet Corporation is a specialty pharmaceutical company developing and
planning to commercialize proprietary, abuse-deterrent oral products for the
treatment of pain and other indications. Egalet has created two distinct drug
delivery systems, each with novel abuse-deterrent features and the ability to
control the release profile of the active pharmaceutical ingredient (API).
Using its proprietary platform, Egalet has developed a pipeline of
clinical-stage, opioid-based product candidates in tablet form that are
specifically designed to deter abuse by physical and chemical manipulation,
while also providing tailored release of the active pharmaceutical ingredient.
Its lead product candidate, Egalet-001, is an abuse-deterrent,
extended-release, oral morphine formulation in development for the treatment
of moderate to severe chronic pain. There are currently no commercially
available abuse-deterrent formulations of morphine, and if approved, Egalet
believes that Egalet-001 would fill a significant unmet need in the
marketplace. Its second product candidate, Egalet-002, is an abuse-deterrent,
extended-release, oral oxycodone formulation in development for the treatment
of moderate to severe chronic pain. The Egalet technology can be applied
broadly across different classes of pharmaceutical products and can be used to
develop combination products that include multiple APIs with similar or
different release profiles. Visit www.egalet.com for more information.

CONTACT: E. Blair Clark-Schoeb
         Tel: 917-432-9275
         Email: blair@biotechcomm.com

Egalet Corporation Logo
 
Press spacebar to pause and continue. Press esc to stop.